| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/13543784.2011.542410 |
| P698 | PubMed publication ID | 21158690 |
| P50 | author | Paul A. Lapchak | Q37838905 |
| P2860 | cites work | Effects of NXY-059 in experimental stroke: an individual animal meta-analysis | Q24654761 |
| Pathobiology of ischaemic stroke: an integrated view | Q28141682 | ||
| ORP150 protects against hypoxia/ischemia-induced neuronal death | Q28202922 | ||
| Prior statin use reduces mortality in intracerebral hemorrhage | Q28219526 | ||
| Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase | Q40580653 | ||
| Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators | Q40791071 | ||
| Matrix metalloproteinases in brain injury | Q40965342 | ||
| The neurovascular unit in health and disease: introduction | Q41884816 | ||
| Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice | Q42474348 | ||
| Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway | Q43202016 | ||
| Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats | Q43272684 | ||
| Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia | Q43599428 | ||
| Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. | Q43984493 | ||
| Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain | Q44131286 | ||
| Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats | Q44691331 | ||
| BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. | Q45022922 | ||
| Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death | Q45055104 | ||
| Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke | Q45140253 | ||
| Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice | Q45268320 | ||
| Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. | Q45993411 | ||
| Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. | Q46009953 | ||
| Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes | Q46060228 | ||
| Potential role of curcumin in stroke prevention | Q46451660 | ||
| Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice | Q46466155 | ||
| A pyrazole derivative of curcumin enhances memory | Q46474860 | ||
| Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. | Q46494840 | ||
| Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. | Q46704364 | ||
| Curcuma oil: reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain | Q46936265 | ||
| Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage | Q48271861 | ||
| Penumbra is brain: no excuse not to perfuse | Q48721546 | ||
| Ischemic stroke subtypes: a population-based study of incidence and risk factors. | Q50654471 | ||
| A prospective community-based study of stroke in Kolkata, India. | Q50797698 | ||
| Bioavailability of curcumin: problems and promises | Q28257125 | ||
| Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q28303699 | ||
| Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke | Q29619330 | ||
| Tissue plasminogen activator for acute ischemic stroke | Q29619377 | ||
| Advances in ischemic stroke treatment: neuroprotective and combination therapies | Q33278117 | ||
| Spatiotemporal correlations between blood-brain barrier permeability and apparent diffusion coefficient in a rat model of ischemic stroke | Q33492311 | ||
| Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia | Q33514599 | ||
| Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia | Q33567203 | ||
| Severe blood-brain barrier disruption and surrounding tissue injury | Q33641948 | ||
| Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development | Q33896024 | ||
| A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? | Q33938450 | ||
| Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa | Q34020709 | ||
| Immunostimulatory activities of polysaccharide extract isolated from Curcuma longa | Q34050121 | ||
| Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats | Q34103128 | ||
| The science of stroke: mechanisms in search of treatments | Q34212337 | ||
| Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke | Q34417300 | ||
| Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment | Q34566668 | ||
| Anti-ischemic effect of curcumin in rat brain | Q34587276 | ||
| A broadly neuroprotective derivative of curcumin | Q34738787 | ||
| Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. | Q34771008 | ||
| Development of thrombolytic therapy for stroke: a perspective | Q35001038 | ||
| Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons | Q35010629 | ||
| The ischemic penumbra: identification, evolution and treatment concepts | Q35615678 | ||
| Treatment with statins in the acute phase of ischemic stroke. | Q36106811 | ||
| Molecular targets in cerebral ischemia for developing novel therapeutics | Q36707914 | ||
| Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke | Q36739429 | ||
| A review of genetic causes of ischemic and hemorrhagic stroke | Q36747543 | ||
| Neuroprotective effects of curcumin | Q36849490 | ||
| Advances in hemorrhagic stroke therapy: conventional and novel approaches | Q36944012 | ||
| Hyperacute treatment initiation in neuroprotective agent stroke trials | Q36954992 | ||
| Optimal management of combined dyslipidemia: what have we behind statins monotherapy? | Q37071543 | ||
| Current status of neuroprotection for cerebral ischemia: synoptic overview | Q37230428 | ||
| Stroke: Indian scenario | Q37357577 | ||
| Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid. | Q37455689 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13-22 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Expert Opinion on Investigational Drugs | Q5421208 |
| P1476 | title | Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective | |
| P478 | volume | 20 |
| Q42030786 | 4-((1E)-2-(5-(4-hydroxy-3-methoxystyryl-)-1-phenyl-1H-pyrazoyl-3-yl) vinyl)-2-methoxy-phenol) (CNB-001) Does Not Regulate Human Recombinant Protein-Tyrosine Phosphatase1B (PTP1B) Activity in vitro |
| Q26781560 | A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions |
| Q89170886 | A11, a novel diaryl acylhydrazone derivative, exerts neuroprotection against ischemic injury in vitro and in vivo |
| Q99624778 | Celastrol dilates and counteracts ethanol-induced constriction of cerebral arteries |
| Q38695551 | Curcumin Protects against Ischemic Stroke by Titrating Microglia/Macrophage Polarization |
| Q38016212 | Curcumin and neurodegenerative diseases: a perspective |
| Q36582307 | Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders. |
| Q38097895 | Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy |
| Q30573979 | Dietary therapy to promote neuroprotection in chronic spinal cord injury |
| Q34432486 | Effect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke. |
| Q35029799 | Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims |
| Q44466965 | Isoquercetin Ameliorates Cerebral Impairment in Focal Ischemia Through Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Effects in Primary Culture of Rat Hippocampal Neurons and Hippocampal CA1 Region of Rats |
| Q38007107 | Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease |
| Q35606190 | Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice |
| Q41195434 | Neuroprotective effect of curcumin on spinal cord in rabbit model with ischemia/reperfusion |
| Q38842458 | Protection of seven dibenzocyclooctadiene lignans from Schisandra chinensis against serum and glucose deprivation injury in SH-SY5Y cells |
| Q36816551 | RIGOR guidelines: escalating STAIR and STEPS for effective translational research |
| Q42000475 | The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies |
| Q38156409 | Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection |
| Q37585357 | Unique mechanisms of sheng yu decoction ( shèng yù tang) on ischemic stroke mice revealed by an integrated neurofunctional and transcriptome analysis |
| Q42024671 | Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets |
Search more.